This website uses cookies
Read our Privacy policy and Terms of use for more information.
These articles cover news, research, tips related to insulin.
Videos
+2
/
Sep 4, 2026
When Levemir was discontinued in the U.S., Allison Smart began a national advocacy effort to bring it back—and to preserve treatment choice for people with diabetes.
News
Aug 19, 2026
Awikli, the first once-weekly basal insulin for type 2 diabetes, has officially launched across the U.S., cutting basal injections down to once a week.
+3
May 29, 2026
Afrezza, the only inhalable mealtime insulin, is now available to children and adolescents signifying a step forward in pediatric diabetes care
Podcast
+1
Apr 20, 2026
Civica Rx is a nonprofit selling insulin for $11 a pen and $30 a vial, cutting out the middlemen and pricing games that have kept it unaffordable for decades.
Product Recs
Apr 3, 2026
These water-activated evaporative cooling cases help keep insulin and other medications within safe temperature ranges during travel and extreme heat.
Apr 2, 2026
The new insulin reduces injections from daily to once-a-week while maintaining effective glucose control demonstrated in phase 3 clinical trials.
Mar 30, 2026
The bill caps insulin costs, forces rebate transparency, and encourages competition to lower prescription prices overall.
ODT
Mar 2, 2026
I sat down with Gary Scheiner CDCES to discuss insulin variability, site failures, unexplained highs, and practical strategies to get insulin working efficiently.
Medtronic
+4
Feb 25, 2026
The MiniMed Go system combines InPen and Simplera CGM into one powerful app for people with insulin-requiring Diabetes
Feb 17, 2026
The first patients have received its investigational Portal Insulin as development moves toward larger trials in 2027.
Feb 12, 2026
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
Jan 13, 2026
MiniMed Go connects InPen to the Instinct continuous glucose monitor to provide dosing alerts and insights to MDI users with type 1 and 2 diabetes.
Dec 29, 2025
I sat down with CDCES Gary Scheiner to discuss why basal insulin matters, how to know when it's off, and what stable basal looks like for insulin pumps and MDI.
Dec 3, 2025
The collaboration could aid insulin delivery for people who require higher doses and extend wear time. Trials are expected to begin in 2026.
Oct 29, 2025
New laws and state-run manufacturing aim to make insulin more affordable to all Californians starting in 2026, setting a national example for diabetes care reform.
Oct 14, 2025
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
Sep 30, 2025
FDA clears Tandem’s t:slim X2 insulin pump for use with Lilly’s ultra-rapid Lyumjev insulin, expanding options beyond Humalog and Novolog.
Research
Sep 24, 2025
We dive into the history of insulin and the breakthroughs on the horizon—from smart insulin and oral treatments to weekly long-acting shots.
We got a first look at the FDA-cleared 7-day SteadiSet infusion set coming to all Tandem pumps in the U.S next year.
Dec 2, 2024
How Luna’s overnight-only design could change the way people with diabetes manage insulin while they sleep.
Aug 5, 2024
We dive into how the CeQur insulin patch delivers 2-unit meals and correction doses with discretion and fewer injections to help make diabetes management simpler.
Apr 8, 2024
Understanding how GLP-1 and GIP medications like Ozempic, Wegovy, and Mounjaro affect blood sugar, appetite, and help with diabetes management.
Feb 5, 2024
This inhalable insulin enters the system faster and leaves the body sooner, making it a great option for treatment for people with diabetes.
Future Tech
Dec 11, 2023
Exploring inhaled options, smart pills, ultra-rapid formulations, and the breakthroughs reshaping insulin therapy.
Jul 7, 2023
A smart pen that tracks insulin doses, offers personalized calculations, and integrates CGM and glucose data to help MDI users make smarter daily decisions.
